Clinical Trial Update: Macrophage Imaging Using Ga-MMR-VHH2 in Lung Cancer Patients [Phase 2]

View source ↗

Summary

Phase 2 clinical trial investigating a gallium-labeled imaging agent Ga-MMR-VHH2 for non-small cell lung cancer patients; recruitment currently ongoing.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Ga-MMR-VHH2

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Non-small Cell Lung Cancer | Phase 2 | Status: RECRUITING